About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Flexible Catheter for Insulin in Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03182569

Flexible Catheter for Insulin in Diabetes

Use of a flexible subcutaneous catheter improves comfort in patients with DKA compared to the usual treatment with a metal needle.

Lead sponsor: Hospital General de Niños Pedro de Elizalde•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hospital General de Niños Pedro de Elizalde

Assess whether the use of a flexible subcutaneous catheter improves comfort in patients with DKA compared to the usual treatment with a metal needle. Compare the metabolic evolution of patients with DKA using a flexible subcutaneous catheter for insulin administration vs. a metal needle.

Age

5 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients aged 5 to 18 years, admitted with diagnoses of DKA. DKA is defined when patients meets all the following biochemical baseline criteria (before initial hydration):
•Glucose\> 200 mg / dl
•pH \< 7.3
•Bicarbonate \< 15mmol/l.

Exclusion Criteria

•Patients referred from another institution with a different treatment, and those who requires intensive care on admission.

Related studies

RECRUITINGPhase 2/3

REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

NCT06955416 · Diabetic Ketoacidosis

Enrolling By InvitationNA

Starvation in the Treatment of Diabetic Ketoacidosis

NCT06186245 · Diabetes Mellitus, Diabetic Ketoacidosis

Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis.

NCT07467616 · Diabetic Ketoacidosis

Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis

NCT06693115 · Diabetic Ketoacidosis, Hyperglycemia

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

NCT07423559 · Diabetic Ketoacidosis, Insulin, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment20

Start dateDec 2016

Last updatedApr 12, 2018

Condition

Diabetic Ketoacidosis

Locations shown

Hospital General de Niños Pedro de Elizalde

Buenos Aires, Constitucion

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions